Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vigil Neuroscience, Inc. | Chief Financial Officer | Stock Option Award (Right to Buy) | 135K | $1.03M | $7.62 | May 3, 2024 | Direct |
Vigil Neuroscience, Inc. | Chief Financial Officer | Stock Option Grant (Right to Buy) | 156K | Mar 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIGL | Vigil Neuroscience, Inc. | May 3, 2024 | 4 | $0 | 4 | May 7, 2024 | Chief Financial Officer |
VIGL | Vigil Neuroscience, Inc. | Mar 1, 2024 | 1 | $0 | 4 | Mar 1, 2024 | Chief Financial Officer |
VIGL | Vigil Neuroscience, Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Chief Financial Officer |
VIGL | Vigil Neuroscience, Inc. | May 3, 2022 | 1 | $15.1K | 4 | May 4, 2022 | Chief Financial Officer |
VIGL | Vigil Neuroscience, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 3, 2022 | Chief Financial Officer |
VIGL | Vigil Neuroscience, Inc. | Jan 6, 2022 | 0 | $0 | 3 | Jan 6, 2022 | Chief Financial Officer |